Erasca, Inc. (ERAS) — Stock Score Summary

Erasca, Inc. (ERAS) has a MoatMap StockRank of 45/100 based on Quality (34/100), Value (36/100), and Momentum (63/100) factor scores. The current signal is HOLD. Erasca is a clinical-stage oncology company. It does not possess the high-ROIC, asset-light, or validated manufacturing characteristics required by our investment lenses.

Erasca, Inc. is a clinical-stage oncology company dedicated to discovering and developing novel small molecule medicines to overcome resistance in difficult-to-treat cancers. The company leverages its proprietary drug discovery platform to target key oncogenic pathways and address mechanisms of resistance to existing therapies. It operates as a specialized biotechnology firm, positioning itself at the forefront of precision oncology with a focused pipeline aimed at improving outcomes for cancer patients.

Key Financial Metrics

Price$13.41
Market Cap$3.8B
P/E (Forward)-23.10
Price/Book10.48
Return on Equity-69.9%
Return on Invested Capital-35.7%
Debt/Equity11.68
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-213M

Erasca, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Erasca, Inc.’s (ERAS) StockRank?
MoatMap’s StockRank for Erasca, Inc. (ERAS) is 45/100, with a Hold signal. It is a composite of Quality (34), Value (36), and Momentum (63) factor ranks across MoatMap’s 19,000+ stock universe.
Does Erasca, Inc. have an economic moat?
Erasca, Inc. (ERAS) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Erasca, Inc. a buy, hold, or sell?
MoatMap’s current signal for Erasca, Inc. (ERAS) is Hold, based on a StockRank of 45/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Erasca, Inc. in?
Erasca, Inc. (ERAS) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksERAS deep dive reportAI ChampionsHow we score stocksSense-check another stock